Market Overview:
The global protein labeling market size is expected to exhibit a growth rate (CAGR) of 8.19% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate (2024-2032) |
8.19% |
Protein labeling refers to the covalent attachment of different molecules, such as biotin, reporter enzymes, fluorophores, and radioactive isotopes, to the target nucleotide sequence. It is achieved by the method of fluorescent fusions, ligases, and self-labeling tags. Nowadays, advanced imaging approaches are adopted to obtain detailed information on the spatial organization and conformational dynamics of individual proteins. As a result, the application of protein labeling is expanding in biological research worldwide to facilitate the detection or purification of the labeled protein and its binding partners.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
The rising utilization of bioengineering technologies represents one of the major factors positively influencing the demand for protein labeling in the healthcare sector. Protein labeling is widely used for biological process monitoring, simplifying detection workflows, reliable quantification of compounds, and specific detection of protein modifications and isoforms in multiplexed samples. Moreover, researchers across the globe are focusing on improving the accuracy, resolution, and procedures of protein labeling techniques to offer an alternative to fluorescent proteins. These technologies are also used to study the function and localization of proteins in living and fixed cells. This, in confluence with the growing prevalence of chronic and lifestyle diseases, is strengthening the market growth. Apart from this, several drugs are in the research and development (R&D) phase. This, along with the increasing adoption of modern molecular tools to enhance the functional mechanisms in drug development, diagnosis, and therapy applications, is anticipated to impel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein labeling market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on labeling method, product, and application.
Breakup by Labeling Method:
- In-Vitro Labeling
- In-Vivo Labeling
Breakup by Product:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Breakup by Application:
- Cell-based Assays
- Fluorescence Microscopy
- Mass Spectrometry
- Immunological Techniques
- Protein Microarray
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cytiva (Danaher Corporation), F. Hoffmann-La Roche Ltd. (Roche Holding AG), Jena Bioscience GmbH, LGC Limited, LI-COR Inc., Merck KGaA, New England Biolabs, PerkinElmer Inc., Promega Corporation and Thermo Fisher Scientific Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Labeling Method, Product, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Agilent Technologies Inc., Cytiva (Danaher Corporation), F. Hoffmann-La Roche Ltd. (Roche Holding AG), Jena Bioscience GmbH, LGC Limited, LI-COR Inc., Merck KGaA, New England Biolabs, PerkinElmer Inc., Promega Corporation and Thermo Fisher Scientific Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |